{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:19:55Z","timestamp":1761707995699},"reference-count":29,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3205,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2006.01180.x","type":"journal-article","created":{"date-parts":[[2006,11,22]],"date-time":"2006-11-22T11:04:39Z","timestamp":1164193479000},"page":"33-37","source":"Crossref","is-referenced-by-count":4,"special_numbering":"supplement s151","title":["Botulinum-A toxin: an exciting new treatment option for prostatic disease"],"prefix":"10.1155","volume":"60","author":[{"given":"C. A.","family":"THOMAS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"GUERCINI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y-C","family":"CHUANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. B.","family":"CHANCELLOR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,11,22]]},"reference":[{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archinte.1995.00430050053006","article-title":"New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United States","volume":"155","author":"Jacobsen","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB2|cit2","volume-title":"Cancer Facts and Figures","author":"American Cancer Society Inc","year":"accessed October 2006"},{"issue":"Suppl. 4","key":"10.1111\/j.1742-1241.2006.01180.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1468-1331.1999.tb00032.x","article-title":"Preclinical update on Botox (botulinum toxin type A) purified neurotoxin complex relative to other botulinum neurotoxin preparations","volume":"6","author":"Aoki","year":"1999","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/01.ju.0000127725.48479.89","article-title":"Emerging role of botulinum toxin in the treatment of voiding dysfunction","volume":"171","author":"Smith","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/01.ju.0000049202.56189.54","article-title":"Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract","volume":"169","author":"Smith","year":"2003","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1097-0045(19980915)37:1<44::AID-PROS7>3.0.CO;2-8","article-title":"Botox induced prostatic involution","volume":"37","author":"Doggweiler","year":"1998","journal-title":"Prostate"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1365-2680.2000.00195.x","article-title":"The autonomic and sensory innervation of the smooth muscle of the prostate gland: a review of pharmacological and histological studies","volume":"20","author":"Pennefather","year":"2000","journal-title":"J Auton Pharmacol"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0163-7258(02)00174-2","article-title":"Cholinergic innervation and function in the prostate gland","volume":"94","author":"Ventura","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0094-0143(21)00960-5","article-title":"Clinical and experimental studies of benign prostatic hyperplasia","volume":"17","author":"Coffey","year":"1990","journal-title":"Urol Clin North Am"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-5347(18)35521-6","article-title":"Intraprostatic botulin toxin injection in patients with severe benign prostatic hyperplasia a multicenter feasibility study","volume":"173","author":"Guercini","year":"2005","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0090-4295(03)00477-1","article-title":"Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study","volume":"62","author":"Maria","year":"2003","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.urology.2005.04.029","article-title":"Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates","volume":"66","author":"Chuang","year":"2005","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0022-5347(05)64541-7","article-title":"Hereditary prostate cancer: clinical aspects","volume":"168","author":"Bratt","year":"2002","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/hmg\/10.20.2313","article-title":"Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease","volume":"10","author":"Nwosu","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1210\/endo.143.6.8890","article-title":"Prostate cancer susceptibility genes","volume":"143","author":"Simard","year":"2002","journal-title":"Endocrinology"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1158\/1078-0432.CCR-05-1222","article-title":"Botulinum toxin potentiates cancer radiotherapy and chemotherapy","volume":"12","author":"Ansiaux","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJM199608223350809","article-title":"Treatment of benign prostatic hyperplasia","volume":"335","author":"Walsh","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB18|cit18","article-title":"Novel action of botulinum toxin on the stromal and epithelial components of prostate gland","author":"Chuang","year":"2006","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.eururo.2005.01.009","article-title":"The distribution of sensory fibers immunoreactive for the TRPV1 (capsaicin) receptor in the human prostate","volume":"48","author":"Dinis","year":"2005","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/01.ju.0000121690.37499.1c","article-title":"Prostatic tissue ablation by injection: a literature review","volume":"172","author":"Plante","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/01.ju.0000142058.99614.ff","article-title":"The role of inflammation in the pathogenesis of prostate cancer","volume":"172","author":"Nelson","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/j.1939-4640.1996.tb01788.x","article-title":"Seminal fluid findings in men with nonbacterial prostatitis and prostatodynia","volume":"17","author":"Krieger","year":"1996","journal-title":"J Androl"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/01.ju.0000136002.76898.04","article-title":"Mechanisms in prostatitis\/chronic pelvic pain syndrome","volume":"172","author":"Pontari","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1365-2680.2000.00195.x","article-title":"The autonomic and sensory innervation of the smooth muscle of the prostate gland: a review of pharmacological and histological studies","volume":"20","author":"Pennefather","year":"2000","journal-title":"J Auton Pharmacol"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.ju.0000137844.77524.97","article-title":"Intravesical botulinum toxin A administration produces analgesia against acetic acid induced bladder pain responses in rats","volume":"172","author":"Chuang","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.urology.2004.06.073","article-title":"Botulinum toxin-A has antinociceptive effects in treating interstitial cystitis","volume":"64","author":"Smith","year":"2005","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB27|cit27","first-page":"??","article-title":"Intraprostatic capsaicin injection as a novel model for non-bacterial prostatitis","author":"Chuang","year":"2006","journal-title":"AUA Proceedings Abstract"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2490-6-12","article-title":"Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs","volume":"6","author":"Chuang","year":"2006","journal-title":"BMC Urol"},{"key":"10.1111\/j.1742-1241.2006.01180.x-BIB29|cit29","doi-asserted-by":"crossref","DOI":"10.1111\/j.1464-410X.2006.06184.x","article-title":"The potential and promise of using botulinum toxin in the prostate gland","author":"Chuang","year":"2006","journal-title":"BJU Int"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2006.01180.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2006.01180.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T11:56:43Z","timestamp":1707393403000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2006.01180.x"}},"subtitle":["BOTULINUM TOXIN IN THE PROSTATE"],"short-title":[],"issued":{"date-parts":[[2006,11,22]]},"references-count":29,"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2006.01180.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11,22]]}}}